Harvard NeuroDiscovery Center

Established in 2001 by Dr. Joseph Martin (Dean of Harvard Medical School, 1997-2007), the Harvard NeuroDiscovery Center is a pioneering biomedical research group focused on ending suffering from neurodegenerative diseases. By drawing on the intellectual strength and proven capability of the Harvard medical community and colleagues throughout the world, the NeuroDiscovery Center has developed a unique approach to understanding and treating these devastating diseases.

Our focus:

• Alzheimer's, Parkinson's, multiple sclerosis, ALS (amyotrophic lateral sclerosis) and other degenerative diseases of the brain.

• Combining academic creativity with a business-like approach to ensure a focused and efficient effort to advance the search for cures.

• Accelerating the pace of progress, from scientific discoveries to meaningful patient treatments.

• Real collaboration across the Harvard Medical community, prominent research centers worldwide and the private sector.

• Applying discoveries about one neurodegenerative disease to better understand the others.

Whereas our ultimate goal is simple — to improve the lives of the millions who face the physical, emotional, and economic burden of neurodegenerative diseases — these diseases represent a far too complex and urgent problem for any one group to tackle. To date, we have engaged over 800 researchers in a growing portfolio of outcome-directed research programs. For visionary philanthropists and scientists, participation in the Harvard NeuroDiscovery Center's work offers the best hope for progress — please join us!